Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics

11 Feb 2022

Abstract excerpt

The world raced to develop vaccines to protect against the rapid spread of SARS-CoV-2 infection upon the recognition of COVID-19 as a global pandemic. A broad spectrum of candidates was evaluated, with mRNA-based vaccines emerging as leaders due to how quickly they were available for emergency use while providing a high level of efficacy. As a modular technology, the mRNA-based vaccines benefitted from decades of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to RNA Interference and Gene Delivery
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35214130
DOI: 10.3390/pharmaceutics14020398

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lipid Nanoparticle Delivery Systems to Enable mRNA-Based TherapeuticsPMID 35214130Read ↗

Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imagingSemantic proximity Read ↗

mRNA Vaccine Platforms and Lipid Nanoparticle Delivery Systems: Molecular Advances, Clinical Breakthroughs, and Regulatory Perspectives (2020–2025)Semantic proximity Read ↗

Engineering of mRNA vaccine platform with reduced lipids and enhanced efficacySemantic proximity Read ↗

The Delivery of mRNA Vaccines for TherapeuticsSemantic proximity Read ↗

Lipid nanoparticles in the development of mRNA vaccines for COVID-19Semantic proximity Read ↗

mRNA therapeutics: beyond vaccine applicationsSemantic proximity Read ↗

Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progressSemantic proximity Read ↗

mRNA vaccines in the prevention and treatment of diseasesSemantic proximity Read ↗

The Platform Technology Approach to mRNA Product Development and RegulationSemantic proximity Read ↗

From structural design to delivery: mRNA therapeutics for cancer immunotherapySemantic proximity Read ↗

Delivering the Message: Translating mRNA Therapy for Liver Inherited Metabolic DiseasesSemantic proximity Read ↗

mRNA Vaccines: Design Principles, Mechanisms, and Manufacturing—Insights From COVID‐19 as a Model for Combating Infectious DiseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.